Favorable decision for PAŻP by the court in Belgium. In the background, a dispute with Pfizer over vaccines

The court confirmed that the funds from route fees belong to PAŻP, not the State Treasury. PAŻP operates independently and is not liable for the State's obligations, meaning its funds cannot be used to satisfy Pfizer's claims against Poland regarding the vaccine purchase agreement. This issue arises from a dispute over Pfizer vaccines that Poland did not accept. A Belgian court ruled in favor of Pfizer, ordering Poland to take delivery of approximately 64 million doses and pay 5.644 billion PLN. Eurocontrol informed PAŻP that accounts receiving navigation fees were seized due to the ruling.